heart failure glp 1 GLP-1 receptor agonists as promising anti-inflammatory agents in with preserved ejection fraction | Heart Failure Reviews European Society of Cardiology/Heart Failure

This activation enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, delays gastric emptying, and reduces appetite through central nervous system pathways

N Engl J Med (2015) 373:224757

Periferik Arter ve Parkinson Hastalarnda Semptomlarn Hafifletilmesini Salar Genellikle bacaklarda grlen periferik arter hastalnda, periferik atar damarlarda tkanklk ve plak oluumu grlebilir

The Reuters report on a head-to-head trial against tirzepatide (February 2026) noted CagriSema did not meet a non-inferiority threshold against tirzepatide on average weight loss at 84 weeks

Cost, Insurance Coverage, and Access Public insurance coverage for GLP-1 obesity treatments is spotty in the United States